Oyepeju Abioye-Akintola: New publication thread alert
Oyepeju Abioye-Akintola, Internal Medicine Resident Physician at Allegheny Health Network, shared on X about a recent paper published in JCO Global Oncology:
“New publication thread alert!
- Thrilled to share our latest pub in JCO Global Oncology on Disparities in Cholangiocarcinoma Research and Trials; co-first authored by myself and Rebekah Kaufman Florez Lab under the incredible guidance of Cecilia Monge B.
Authors: Oyepeju F. Abioye, Rebekah Kaufman, Tim F. Greten, and Cecilia Mong
2. Cholangiocarcinoma is a devastating hepatic cancer with rising global incidence and poor prognosis. Yet the communities most affected are systematically under represented in research and clinical trials.
3. Asian, Hispanic, Indigenous, Alaskan Native, Pacific Islander, and Black populations experience higher incidence and worse outcomes, but are often left out of the data and trials that shape care standards. This is a huge gap.
4. Social determinants of health like insurance status, immigration background, and geographic access create delays in diagnosis and treatment. Lower SDIs are linked to higher ASRs, further widening the gap in outcomes.
5. Trial underrepresentation limits our ability to develop effective, personalized therapies. Without diverse cohorts, data-driven action remains inadequate, at best.
6. We highlight the urgent need for:
- More inclusive and robust databases and biobanks
- Better trial design and recruitment
- Investment in populations that bear the highest burden
7. Bottom line: addressing incidence and mortality inequities in the management of patients with cholangiocarcinoma requires deliberate action across clinical trial recruitment, research, policy, and clinical practice.
8. Read the full paper.
Save, share, and join the conversation on Cholangiocarcinoma.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023